Article: Targeted vaccine may help immune system fight cancer.(Brief Article)

2002 JUN 12 - (NewsRx.com & NewsRx.net) -- Completing an important step in the evaluation of a cancer vaccine that has the potential to selectively target a wide range of tumors, researchers at the Ludwig Institute for Cancer Research report that the NY-ESO-1 ISCOM vaccine safely activated a specific immune response in most cancer patients.

The results, presented at the American Society of Clinical Oncology annual meeting in Orlando, Florida, demonstrate for the first time that a NY-ESO-1 full-length protein can stimulate anticancer defenses.

"There are a number of vaccine strategies that might work against cancer, but NY-ESO-1 proteins are particularly ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!